H40.43X2 Glaucoma secondary to eye inflammation, bilateral, moderate stage

Name of the Condition

• Glaucoma Secondary to Eye Inflammation, Bilateral, Moderate Stage

Summary

Glaucoma secondary to eye inflammation, bilateral, moderate stage, is a condition where increased intraocular pressure (IOP) or optic nerve damage occurs as a result of inflammatory processes affecting both eyes. This form of glaucoma may develop due to acute or chronic inflammation disrupting the eye’s drainage structures or optic nerve, potentially leading to vision loss if not managed. The term "bilateral" specifies that both eyes are affected, while "moderate stage" indicates the condition is in a mid-phase of progression.

Causes

The condition arises from inflammation that disrupts the eye’s normal fluid drainage or damages the optic nerve. Common mechanisms include uveitis, scleritis, or other inflammatory disorders that affect the trabecular meshwork, angle structures, or optic nerve head. Inflammation may be acute (sudden onset) or chronic (long-standing), and the underlying cause of the inflammation (e.g., autoimmune, infectious) is not specified in this code.

Risk Factors

• Chronic or recurrent eye inflammation (e.g., uveitis).
• Autoimmune conditions (e.g., rheumatoid arthritis, sarcoidosis).
• Infections affecting the eye (e.g., viral or bacterial).
• Prior eye surgery or trauma that triggers inflammation.
• Use of topical or systemic medications that induce ocular inflammation.

Symptoms

• Elevated intraocular pressure (detected via tonometry).
• Vision changes, such as blurred vision or peripheral vision loss.
• Eye pain or discomfort.
• Redness or swelling of the eye.
• Headaches, particularly around the eye.

Diagnosis

Diagnosis involves a comprehensive eye examination, including tonometry to measure IOP, visual field testing to assess optic nerve damage, and slit-lamp examination to evaluate eye structures. Imaging or additional tests may be used to identify inflammation or rule out other causes. Documentation of bilateral involvement and moderate stage progression is required for accurate coding.

Treatment Options

Treatment focuses on reducing inflammation and lowering IOP. Options may include anti-inflammatory medications (e.g., corticosteroids), IOP-lowering drugs (e.g., prostaglandin analogs), or surgical interventions (e.g., trabeculectomy). Management is tailored to the underlying inflammatory cause and severity of the condition.

Prognosis and Follow-Up

Prognosis depends on early detection and effective management of inflammation and IOP. Regular follow-up appointments are essential to monitor IOP, optic nerve health, and vision. Untreated or poorly controlled inflammation may lead to progressive vision loss.

Complications

• Permanent vision loss or blindness.
• Optic nerve damage.
• Corneal scarring or clouding.
• Cataracts.
• Increased risk of other eye conditions.

Lifestyle & Prevention

• Manage underlying inflammatory conditions with medical guidance.
• Avoid eye injuries or irritants.
• Follow prescribed treatment regimens consistently.
• Maintain regular eye examinations to detect changes early.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, severe eye pain, or persistent redness. Regular check-ups are recommended for those with risk factors or a history of eye inflammation.

Tips for Medical Coders

Document bilateral involvement and moderate stage progression clearly in the medical record. Ensure the inflammatory cause is specified if known, as this may impact coding accuracy. Verify that the stage (moderate) is supported by clinical findings or documentation.